期刊文献+

粪菌移植对腹泻型肠易激综合征的疗效观察 被引量:16

Curative effect of fecal microbiota transplantation on diarrhea predominant irritable bowel syndrome
原文传递
导出
摘要 [目的]观察粪菌移植对腹泻型肠易激综合征的临床疗效。[方法]将42例腹泻型肠易激综合征患者随机分为治疗组和对照组,2组患者均进行生活饮食调理,给予口服益生菌制剂,治疗组在此基础上给予粪菌移植。对2组临床疗效进行评价,并记录不良反应。[结果]治疗组显效率(60.0%)高于对照组(18.5%),2组比较差异有统计学意义(χ~2=7.47,P<0.01);治疗组总有效率80.0%,对照组总有效率55.6%,2组比较差异无统计学意义(χ~2=2.51,P>0.05);2组治疗后菌群数量均较治疗前有增加,治疗组增加更显著;2组均未见明显不良反应。[结论]粪菌移植能有效缓解腹泻型肠易激综合征患者的临床症状,且不良反应少。 [Objective]To investigate the therapeutic effect of fecal microbiota transplantation on diarrhea predominant irritable bowel syndrome.[Methods]Forty-two cases of patients with IBS-D were divided randomly into observation group and control group.Both groups were given routine medical treatment such as diet adjustment and probiotics,the therapy group were treated with t fecal microbiota transplantation.Curative effect and adverse reaction were observed.[Results]The significant efficiency of the therapy group was higher than that of the control group(60.0% vs 18.5%,X^2=7.47,P<0.01).The total efficiency rate of the two groups had no significant difference(80.0% vs 55.6%,X^2=2.51,P>0.05).[Conclusions]The symptoms in patients with IBS-D can be relieved effectively by fecal microbiota transplantation with less adverse reaction.
作者 郭锐芳 董琳 康东 冶正财 邓燕红 马岚 刘晗 高丽萍 GUO Rui-fang;DONG Lin;KANG Dong;YE Zheng-cai;DENG Yan-hong;MA Lan;LIU Han;GAO Li-ping(The Peoples Hospital of Ningxia,Yinchuan 750004,China)
出处 《临床消化病杂志》 2018年第6期366-368,共3页 Chinese Journal of Clinical Gastroenterology
基金 宁夏卫生计生委重点研究课题(No:2015-NW-009)
关键词 腹泻型肠易激综合征 粪菌移植 临床疗效 diarrhea predominant irritable bowel syndrome fecal microbiota transplantation clinical effect
作者简介 通信作者,董琳,E-mail:grf4641075@163.com
  • 相关文献

参考文献3

二级参考文献20

  • 1Fa-Ming Zhang,Hong-Gang Wang,Min Wang,Bo-Ta Cui,Zhi-Ning Fan,Guo-Zhong Ji.Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease[J].World Journal of Gastroenterology,2013,19(41):7213-7216. 被引量:85
  • 2Douglas A.Drossman,蒋晓玲(译),萧树东(校).罗马Ⅲ:新的标准[J].胃肠病学,2006,11(12):705-707. 被引量:514
  • 3Niv E, Naftali T, Hallak R, et al. The efficacy of Lactobacillusreuteri ATCC 55730 in the treatment of patients with irrita blebowel syndrome-a double blind,placebo controlled,radomized study[J]. Clin Nutr,2005,24:925-931.
  • 4Niedzielin K, Kordecki H, Birkenfeld B. A controlled, doubleblind, randomized study on the efficacy of Lactobaeillus plan tarum 299V in patients with irritable bowel syndrome[J]. Eur J Gastroenterol Hepatol, 2001,13 : 1143-1147.
  • 5LOVELL RMI,FORD AC.Global prevalence of and risk factors for irritable bowel syndrome:a meta-analysis[J].Clin Gastroenterol Hepatol,2012'10(7):712-721.
  • 6JINSONG LIU,XIAOHUA HOU.A review of the irritable bowel syndrome investigation on epidemiology,pathogenesis and pathophy- siology in China[J].Journal of Gastroenterology and Hepatology,2011,26(3):88-93.
  • 7葛均波,徐永健.肠易激综合征[M].内科学(第8版).人民卫生出版社,2013(3):399-401.
  • 8SHEKHAR C,WHORWELL PJ.Emerging drugs for irritable bowel syndrome[J].Expert Opin Emerg Drugs,2009,14(4):673-685.
  • 9LARSSON E,TREMAROLI V,LEE YS,et al.Analysis of gutmicrobial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through My D88 Gut,2012,61(8):1124-1131.
  • 10AZIZ Q,DORE J,EMMANUEL A,et al.Gut microbiota and gastrointestinal health:current concepts and future directions[J].Neurogastroenterol,2013,25(1):4-15.

共引文献39

同被引文献123

引证文献16

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部